About CIMED
CIMED is a Healthcare company based in Bengaluru (India) by Chandrakala Pidathala. A CRO specializing in therapeutics and chronic disease management through innovative solutions. It operates on a B2B model. Its Indian entity Composite Interceptive Med-Science Laboratories Private Limited reported revenue of ₹19.3 Lakh. Its focus areas include Pharmaceuticals, Clinical Research and Disease Management.
Company details
CIMED, led by Chandrakala Pidathala as Co-Founder, specializes in providing healthcare solutions, producing pharmaceutical products, clinical research, and disease management. A CRO specializing in therapeutics and chronic disease management through innovative solutions. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
- Headquarters Bengaluru, India
- Employees 3
- Founders Chandrakala Pidathala
- SectorsHealthcare
- Website cimedlife.com
- Legal Name Composite Interceptive Med-Science Laboratories Private Limited
- Date of Incorporation 05 Jan, 2018
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹19.3 Lakh
FY 2024 · -64% YoY
- Net Loss-₹2.23 Cr
FY 2024 · -1153% margin
- EBITDA-₹1.10 Cr
FY 2024 · -569% margin
- Employee Count3
Associated legal entities of CIMED
CIMED operates through Composite Interceptive Med-Science Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Composite Interceptive Med-Science Laboratories Private Limited CIN U73100KA2018PTC109264 | Active | 05 Jan 2018 | Bengaluru, Karnataka | ₹0.2 Cr | 3 | 2 | View details |
Board of directors of Composite Interceptive Med-Science Laboratories Private Limited (CIMED)
Composite Interceptive Med-Science Laboratories Private Limited is the primary company behind CIMED. The board of Composite Interceptive Med-Science Laboratories Private Limited currently have 2 directors; the longest-serving is Paul Christadas Salins, appointed in 2018. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Paul Christadas Salins DIN 03550224 | Director | 05 Jan 2018 | 8 yrs 10 mo | Composite Interceptive Med-Science Laboratories Private Limited |
| Samarth Shetty DIN 05017333 | Director | 25 Aug 2025 | 1 yr 2 mo | Composite Interceptive Med-Science Laboratories Private Limited |
People of CIMED
1 people are tracked at CIMED (1 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Chandrakala Pidathala | Co-Founder | Leadership |
Complete people profiles for CIMED
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of CIMED
Figures of Composite Interceptive Med-Science Laboratories Private Limited, the primary company behind CIMED, for FY 2024. Revenue was ₹19.3 Lakh (-64% year on year). Net loss was -₹2.23 Cr (-1153% margin). EBITDA was -₹1.10 Cr (-569% margin). Revenue has grown at a compounded annual rate of -26% over three years.
- ₹19.3 LakhRevenue · FY 2024 · -64% YoY
- -₹2.23 CrNet loss · -1153% margin
- -₹1.10 CrEBITDA · -569% margin
- ₹2.07 CrPaid-up capital
- 3Employees (provident fund records)
- -26%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Composite Interceptive Med-Science Laboratories Private Limited are on its company page.
Detailed financial statements for CIMED
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cimed
Complete news archive for CIMED
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CIMED
CIMED is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
CIMED has 3 employees.
The primary company behind CIMED, Composite Interceptive Med-Science Laboratories Private Limited, reported revenue of ₹19.3 Lakh for FY 2024, down 64% year on year.
CIMED, led by Chandrakala Pidathala as Co-Founder, specializes in providing healthcare solutions, producing pharmaceutical products, clinical research, and disease management. A CRO specializing in therapeutics and chronic disease management through innovative solutions. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
CIMED operates through Composite Interceptive Med-Science Laboratories Private Limited.
The legal entities of CIMED currently have 2 directors, including Samarth Shetty, Paul Christadas Salins.